S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › BRO › Research report
← BRO page
XStocksXray
Research report · 16 October 2026

Brown & Brown, Inc. (BRO)

Financials · Insurance Brokers · US stock · price as of 16 Oct 2026

Key indicators

Price$69.40
52-week range$53.69 – $92.02
Market cap$23.2B
P/E (trailing)18.9×
EV / EBITDA15.4×
Free-cash-flow yield6.2%
Dividend yield1.0%
Revenue (last 12 months)$6.8B
Revenue growth (3y a year)18.2%
Operating margin28.7%
Return on invested capital7.7%
Net debt / EBITDA3.7×

Fair value

Blended fair value$101.63 range $90 – $110
Versus priceUndervalued+46% to fair value
Peer multiples$48.94
Fundamentals-adjusted multiple$109.31
10-year DCF (market-scaled)$146.62
Earnings power value (floor, not blended)$42.14
Model uncertaintyMedium

X-Ray Score

53/ 100 · High confidence · ahead of 65% of sector peers
Valuation64
Growth71
Profitability49
Financial health22
Dividends63

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

47.4067.3487.28107127Fair value $1022021-102023-012024-042025-072026-10

Executive summary

Brown & Brown is an insurance brokerage that arranges property, casualty, employee benefits and specialty coverage for businesses and individuals, working through many offices in the United States and abroad. It does not take underwriting risk itself. Instead it earns commissions and fees from insurance carriers and clients, and it has expanded largely by acquiring other brokerage firms.

Sales totalled $6.8 billion over the last twelve months, and the three-year record shows growth of 18.2% a year. The operating margin is 28.7%, and the return on invested capital is 8%. The balance sheet shows net debt to EBITDA of 3.7 times. Shareholders receive a dividend, currently yielding 1.0%.

StocksXray gives Brown & Brown, Inc. an X-Ray Score of 53 out of 100 (high confidence), ahead of 65% of the S&P 500 stocks in its sector. Its strongest lens is growth (71) and its weakest is financial health (22).

Our fair value blend is $101.63 (range $90.31 to $110.38). At $69.40 the stock trades 32% below that blend, so the label is "Undervalued" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Brown & Brown, Inc. (BRO)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$67.93$55.44$69.71$100.60$79.10$69.40
Market cap$18.8B$15.5B$19.6B$28.6B$24.8B$23.2B
P/E32.8×23.4×22.9×29.1×25.0×18.9×
EV / revenue6.6×5.2×5.3×6.6×5.3×4.4×
EV / EBITDA24.4×18.4×17.0×21.2×18.8×15.4×
Price / free cash flow24.7×18.7×20.8×26.2×17.9×16.0×
Free-cash-flow yield4.1%5.4%4.8%3.8%5.6%6.2%
Price / book4.5×3.4×3.5×4.4×2.0×1.8×
Dividend yield0.56%0.76%0.69%0.54%0.78%0.95%

Fundamentals checklist ● 4 Good · ● 7 Average · ● 4 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−1.1%Average
Free-cash-flow yield6.2%Average

Risk models

Altman Z score2.2×Average
Piotroski F-Score3 of 9Bad

Growth

EPS growth (3y)10.1%Average
Free-cash-flow growth (3y)18.6%Average
Revenue growth (3y)18.2%Good
Growth consistency100%Good

Balance sheet

Current ratio1.1×Good
Net debt / EBITDA3.7×Bad
Interest cover4.9×Bad

Valuation

Fair value vs price1.5×Good
EBIT / EV yield6.4%Average

Profitability

Return on invested capital7.7%Bad
Operating margin28.7%Average

Red flags

  • Heavy dilution — Share count up more than 5% year on year
stocksxray.com · page 2
XStocksXray
Brown & Brown, Inc. (BRO)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue3,0513,5734,2574,8055,9026,790
Gross profit––––––
Operating income8281,0171,3361,4961,6681,947
Net income5876728719931,0541,205
Diluted EPS ($)2.072.373.053.463.163.66
Free cash flow7648299411,0921,3821,446
Gross margin––––––
Operating margin27.1%28.5%31.4%31.1%28.3%28.7%
Net margin19.2%18.8%20.5%20.7%17.9%17.7%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets9,79513,97414,88317,61229,99129,887
Cash6936507006751,079918
Total debt2,0233,9423,7963,8247,6137,759
Equity4,1974,6075,5796,43712,57312,608
Dividend per share ($)0.380.420.480.540.62–

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%10%21%31%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)1,4041,2851,6061,6071,9011,676
Growth vs a year earlier+11.6%+9.1%+35.4%+35.8%+35.4%+30.4%
Net income ($M)331231227264426288
Diluted EPS ($)1.150.780.68–1.060.84
stocksxray.com · page 3
XStocksXray
Brown & Brown, Inc. (BRO)

Peers in Insurance Brokers

CompanyX-Ray
BRO · Brown & Brown, Inc.53
AON · Aon plc50
MRSH · Marsh & Mclennan Companies...50
WTW · Willis Towers Watson PLC43
AJG · Arthur J. Gallagher & Co.38

Market Compass outlook for Financials: Favourable (72/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+10.4%
1 month+6.6%
3 months+0.9%
6 months+3.0%
1 year−25.4%
3 years−0.7%
5 years+19.9%

Technical summary

DailyBullish11 bullish · 1 neutral · 4 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bearish1 bullish · 1 neutral · 6 bearish
50-day / 200-day average$67.19 / $66.87
52-week low / high$53.69 / $92.02
Classic pivot, support and resistanceS2 67.74 · S1 68.57 · P – · R1 69.85 · R2 70.30

Recent dividends

Ex-dividend dateAmount per share
12 Aug 2026$0.1650
11 May 2026$0.1650
4 Feb 2026$0.1650
5 Nov 2025$0.1650
13 Aug 2025$0.1500
12 May 2025$0.1500
stocksxray.com · page 4
XStocksXray
Brown & Brown, Inc. (BRO)

Strengths

  • Revenue growth of 18.2% a year over three years is ahead of 89% of its sector peers.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • Piotroski F-Score is weak against Financials peers (3 of 9).
  • Net debt / EBITDA is weak against Financials peers (3.7×).
  • Interest cover is weak against Financials peers (4.9×).
  • Return on invested capital is weak against Financials peers (7.7%).
  • Red flag: Heavy dilution (Share count up more than 5% year on year).

Latest SEC filings

DateFormItems
10 Sep 20268-K7.01,9.01
10 Aug 20268-K5.02
27 Jul 202610-Q
27 Jul 20268-K2.02,9.01
5 Jun 20268-K1.01,2.03
7 May 20268-K5.02,5.07
27 Apr 202610-Q
27 Apr 20268-K2.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026